Antisense therapy for cancer—the time of truth
- 30 November 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (11), 672-683
- https://doi.org/10.1016/s1470-2045(02)00903-8
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001
- Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structureJournal of Molecular Biology, 1999
- Mapping of RNA accessible sites for antisense experiments with oligonucleotide librariesNature Biotechnology, 1998
- Induction of Apoptosis in Small-Cell Lung Cancer Cells by an Antisense Oligodeoxynucleotide Targeting the Bcl-2 Coding SequenceJNCI Journal of the National Cancer Institute, 1997
- Selecting effective antisense reagents on combinatorial oligonucleotide arraysNature Biotechnology, 1997
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Site specific enzymatic cleavage of RNANucleic Acids Research, 1979
- Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proceedings of the National Academy of Sciences, 1978
- Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.Proceedings of the National Academy of Sciences, 1977
- Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloro-ethylamine and nitrogen mustard residues.Tetrahedron Letters, 1967